|
LHFPL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.406000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.185800E-01 |
| Normal-vs-Stage2 |
3.534200E-01 |
| Normal-vs-Stage3 |
8.952400E-01 |
| Normal-vs-Stage4 |
1.669580E-01 |
| Stage1-vs-Stage2 |
5.218200E-01 |
| Stage1-vs-Stage3 |
4.407400E-01 |
| Stage1-vs-Stage4 |
2.328300E-02 |
| Stage2-vs-Stage3 |
2.591200E-01 |
| Stage2-vs-Stage4 |
2.028000E-02 |
| Stage3-vs-Stage4 |
1.829960E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.549800E-01 |
| Normal-vs-AfricanAmerican |
7.111800E-01 |
| Normal-vs-Asian |
1.200230E-02 |
| Caucasian-vs-AfricanAmerican |
9.150600E-01 |
| Caucasian-vs-Asian |
2.0408999999999E-05 |
| AfricanAmerican-vs-Asian |
8.575800E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.430000E-01 |
| Normal-vs-Female |
8.477600E-01 |
| Male-vs-Female |
9.839800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.630400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.806600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.945800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.420400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.855600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.816400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.473000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.956000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.083800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.188000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.322200E-03 |
| Classical-VS-Follicular |
9.978000E-01 |
| Classical-VS-Other |
7.874800E-01 |
| Classical-VS-Normal |
6.559800E-01 |
| Tall-VS-Follicular |
2.458300E-02 |
| Tall-VS-Other |
4.029200E-01 |
| Tall-VS-Normal |
7.864300E-02 |
| Follicular-VS-Other |
7.901800E-01 |
| Follicular-VS-Normal |
7.008600E-01 |
| Other-VS-Normal |
7.156000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.295800E-01 |
| Normal-vs-N1 |
6.459300E-03 |
| N0-vs-N1 |
1.97999999995702E-06 |
|
|
